Compare VNDA & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VNDA | AUDC |
|---|---|---|
| Founded | 2002 | 1992 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 425.5M | 267.0M |
| IPO Year | 2006 | 1999 |
| Metric | VNDA | AUDC |
|---|---|---|
| Price | $8.19 | $8.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $13.13 | $11.67 |
| AVG Volume (30 Days) | ★ 2.8M | 82.5K |
| Earning Date | 02-12-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 4.58% |
| EPS Growth | N/A | ★ 15.76 |
| EPS | N/A | ★ 0.46 |
| Revenue | $212,074,000.00 | ★ $244,553,000.00 |
| Revenue This Year | $12.01 | $2.98 |
| Revenue Next Year | $21.57 | $3.40 |
| P/E Ratio | ★ N/A | $18.80 |
| Revenue Growth | ★ 11.12 | 0.15 |
| 52 Week Low | $3.81 | $8.01 |
| 52 Week High | $9.60 | $12.72 |
| Indicator | VNDA | AUDC |
|---|---|---|
| Relative Strength Index (RSI) | 68.93 | 42.24 |
| Support Level | $6.87 | $8.79 |
| Resistance Level | $9.60 | $8.96 |
| Average True Range (ATR) | 0.49 | 0.18 |
| MACD | 0.13 | -0.02 |
| Stochastic Oscillator | 60.87 | 5.45 |
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.